Dianthus Therapeutics DNTH Accounts Payable Accrued Expenses And Operating Lease Liabilities
Accounts Payable Accrued Expenses And Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept dnth:AccountsPayableAccruedExpensesAndOperatingLeaseLiabilities.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's accounts payable accrued expenses and operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's accounts payable accrued expenses and operating lease liabilities?
- Dianthus Therapeutics (DNTH) reported accounts payable accrued expenses and operating lease liabilities of $7M in Q1 2026.
- How has Dianthus Therapeutics's accounts payable accrued expenses and operating lease liabilities changed year-over-year?
- Dianthus Therapeutics's accounts payable accrued expenses and operating lease liabilities increased by 566.6% year-over-year, from -$1.5M to $7M.
- What does accounts payable accrued expenses and operating lease liabilities mean?
- This aggregate metric represents the net change in short-term liabilities, including trade payables, accrued operational costs, and lease obligations. It serves as a proxy for the company's management of working capital and its ability to defer cash outflows. A positive change indicates an increase in liabilities, which effectively preserves cash for other operational needs.